Sutro Biopharma Inc (STRO)
3.46
-0.39
(-10.13%)
USD |
NASDAQ |
Jun 14, 16:00
3.465
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Cash from Investing (Quarterly): 64.10M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 64.10M |
December 31, 2023 | -23.51M |
September 30, 2023 | -114.02M |
June 30, 2023 | 66.16M |
March 31, 2023 | 67.45M |
December 31, 2022 | -37.88M |
September 30, 2022 | -78.04M |
June 30, 2022 | 47.92M |
March 31, 2022 | 32.98M |
December 31, 2021 | 20.78M |
September 30, 2021 | -2.242M |
June 30, 2021 | 5.876M |
March 31, 2021 | -121.73M |
Date | Value |
---|---|
December 31, 2020 | 15.81M |
September 30, 2020 | 0.296M |
June 30, 2020 | -57.14M |
March 31, 2020 | 41.64M |
December 31, 2019 | 7.942M |
September 30, 2019 | 9.812M |
June 30, 2019 | 9.194M |
March 31, 2019 | -78.08M |
December 31, 2018 | 2.025M |
September 30, 2018 | -81.82M |
June 30, 2018 | -0.036M |
March 31, 2018 | -0.364M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-121.73M
Minimum
Mar 2021
67.45M
Maximum
Mar 2023
-2.230M
Average
8.568M
Median
Cash from Investing (Quarterly) Benchmarks
AnaptysBio Inc | 68.62M |
ABVC BioPharma Inc | -- |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | -0.088M |
Journey Medical Corp | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -64.74M |
Cash from Financing (Quarterly) | -3.429M |
Free Cash Flow | -119.18M |
Free Cash Flow Per Share (Quarterly) | -1.061 |
Free Cash Flow to Equity (Quarterly) | -61.13M |
Free Cash Flow to Firm (Quarterly) | -59.89M |
Free Cash Flow Yield | -56.62% |